Gerald E. Finken

Disruptor, innovator, and pioneer of direct-to-patient #clinicaltrial services

[Gerald E. Finken @geraldfinken]

There is no question that accountability in #clinicaltrials is an important factor. However, having a tool to measure these things does not equate to #accountability or solving the problem. Involving your local #communitypharmacist does.
https://t.co/OwNBWPXlH3

[Gerald E. Finken @geraldfinken]

I could not agree more that nurses are an important resource and play a huge role in #healthcare, but #pharmacists see patients more frequently and create trusted relationships over the long term. They are ready to participate in #clinicaltrials.
https://t.co/6sLnBKvkLx

[Gerald E. Finken @geraldfinken]

While #pharma has been talking about future contributions from RWD/RWE, #communitypharmacists are collecting that real world data and evidence. By applying it, we have improved patient outcomes for decades; we are doing the same for #clinicaltrials.
https://t.co/Lx06ish6n9

[Gerald E. Finken @geraldfinken]

The industry lacks awareness of #clinicaltrials and the importance of #healthcare professionals in driving patient participation and adherence to protocols. Trusted community pharmacists are the solution.
https://t.co/RwhRysQ2VA

[Gerald E. Finken @geraldfinken]

Tech gaps in underserved communities hinder #clinicaltrials. Trust in #communitypharmacists is key. They raise trial awareness and address health determinants. Independent pharmacists bridge the gap, ensuring better outcomes. @merck

https://t.co/gUuOGRehGX

[Gerald E. Finken @geraldfinken]

Important to differentiate local independent #pharmacies from corporate chains for pharmacists' working conditions. Ignoring this undermines local dedication @pharmacists. Corporate practices contribute to financial struggles
https://t.co/VSAaEfyvwP

[Gerald E. Finken @geraldfinken]

What path does your #clinicalsupplychain take? Is it a circuitous route through packaging, labeling, and shipping or a direct line from manufacturing to #dispensing? RxE2 is disrupting the #clinicalsupply chain to improve quality and eliminate waste.

[Gerald E. Finken @geraldfinken]

Where do #clinicalsupply project managers spend most of their time? Figuring out inventory, how to seed sites, getting inventory to sites, storage, and managing limited drug supply. Wouldn’t it be easier to ship to a central-fill #pharmacy for #dispensing directly to the patient?

[Gerald E. Finken @geraldfinken]

@RXE2llc we are strongly committed to community-based decentralized trials, led by #communitypharmacists, the trusted #healthcare professionals who know the community best.
https://t.co/woFZd9vNnp

[Gerald E. Finken @geraldfinken]

Having impeccable site staff and a bulletproof protocol means nothing if you can't recruit patients for your clinical trial. What can improve #clinicaltrial enrollment? Is it trust? Well-established relationships? Access to patients? #communitypharmacists have it all.

[Gerald E. Finken @geraldfinken]

@THREADresearch RXE2 services address this challenge Our E2 precision patient recruitment de-risks clinical trial operations and reduces costs. It also ensures #Diversity Equity & Inclusion (DEI) compliance.

https://t.co/4zw8UGkNbk

[Gerald E. Finken @geraldfinken]

We agree with Noah Goodson at @THREADresearch that for a #clinicaltrial to be human-centered, every user must be considered. Technology must work for clinical researchers, principal investigators, data managers, and clinical trial participants.🧵

https://t.co/woFZd9vNnp

[Gerald E. Finken @geraldfinken]

#COMMUNITYPHARMACISTS = THE BRIDGE TO THE COMMUNITY AND #CLINICALTRIALS

[Gerald E. Finken @geraldfinken]

For successful #clinicaltrial recruitment, sponsors must ensure the inclusion of diverse & underrepresented groups, have effective inclusion & exclusion criteria & have flawless outreach & recruitment strategies. Even then, sponsors rarely have the most necessary ingredient:TRUST

[Gerald E. Finken @geraldfinken]

Join me in Florida at #PharmSci360 later this month! Looking forward to introducing and presenting the pharmacists perspective for #clinicaltrials as a care option.
Monday, October 23, 2023 | 7:00 AM – 9:00 AM ET | Location:308 AB West

[Gerald E. Finken @geraldfinken]

Sponsors must proactively consider #clinicaltrial diversity and the potential impact that a lack of #diversity may have on trial outcomes and generalizability.

[Gerald E. Finken @geraldfinken]

Recruiting study participants is one of the most challenging tasks in the #clinicaltrial process and arguably one of the biggest barriers to success in #clinicalresearch.

[Gerald E. Finken @geraldfinken]

"The value of #clinicalresearch is in developing new therapies and better medications for Everyone, Everywhere™. #Communitypharmacists are essential untapped resources for improved #clinicaltrial outcomes.

"

[Gerald E. Finken @geraldfinken]

Agree that for a #clinicaltrial to be human-centered, every user must be considered. #Technology must work for clinical researchers, principal investigators, data managers, and clinical trial participants.
https://t.co/woFZd9vNnp

[Gerald E. Finken @geraldfinken]

"For decades, #clinicaltrials have faced the same challenges - patient recruitment, patient numbers and diversity, adherence and retention.

With patient trust, personal relationships, and regular one-on-one interactions, #communitypharmacists address these challenges."